Clinical Study for Evaluating ESO-T01 Injection's Safety and Efficacy in Treating Relapsed/refractory Multiple Myeloma
Latest Information Update: 30 Jan 2025
Price :
$35 *
At a glance
- Drugs ESOT 01 (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
- 30 Jan 2025 New trial record